Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.72M 19.13M 17.68M 33.51M 2.26B 34.18M 230M 89.36M 1.11B 88.72M 86.77M 3.84B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37M 34.16M 31.57M 59.83M 4.04B 61.03M 411M 160M 1.98B 158M 155M 6.86B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 day+2.86%
1 week-12.20%
Current month-12.20%
1 month-14.29%
3 months-10.00%
6 months-18.18%
Current year+9.09%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0.01
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.85
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%-12.20%-52.00%+140.00% 1.37M
-0.14%+2.33%+55.24%+623.83% 2.72B
+1.68%-0.77% - - 1.93B
-7.84%-5.05%-38.36%-59.22% 1.85B
+2.50%+6.26%+140.82%+785.42% 1.72B
-1.86%+15.03%-37.07%+39.87% 1.21B
-1.77%-2.89%+300.34%+914.20% 1.11B
+0.55%-1.71%+48.56%+37.77% 923M
+2.22%-8.30%+63.73%+72.24% 895M
+0.87%+1.76%-41.07%-89.05% 441M
Average -0.10%+0.27%+48.91%+273.90% 1.28B
Weighted average by Cap. -0.69%+1.17%+63.87%+373.73%

Financials

2015 2016
Net sales 25.48M 22.35M 20.63M 19.07M 36.14M 2.44B 36.86M 248M 96.38M 1.19B 95.69M 93.59M 4.14B 32.33M 28.36M 26.18M 24.19M 45.85M 3.1B 46.77M 315M 122M 1.51B 121M 119M 5.26B
Net income 5.49M 4.82M 4.45M 4.11M 7.79M 526M 7.95M 53.49M 20.78M 257M 20.63M 20.18M 894M 2.06M 1.81M 1.67M 1.54M 2.92M 197M 2.98M 20.07M 7.8M 96.58M 7.74M 7.57M 335M
Net Debt 24.8M 21.76M 20.09M 18.56M 35.18M 2.38B 35.88M 241M 93.82M 1.16B 93.15M 91.11M 4.03B 18.56M 16.28M 15.03M 13.89M 26.32M 1.78B 26.85M 181M 70.2M 870M 69.7M 68.17M 3.02B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
346
Date Price Change Volume
08/07/26 $0.003600 +2.86% 2,730
  1. Stock Market
  2. Stocks
  3. AOXG Stock